Publications scientifiques

Sobrin L, Seddon JM. 2014. Nature and nurture – genes and environment – predict onset and progression of macular degeneration. Progr Retinal Eye Res, 40: 1-15.

Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013– 2023. (2012).

Fritsche LG, Chen W, Schu M et al. 2013. Seven new loci associated with age-related macular degeneration. Nat Genet, 45(4): 433-439 (http://www.ncbi.nlm.nih.gov/pubmed/24374240)

MATA et al, 2013 Visual Cycle Modulation: A Novel Therapeutic Approach For Treatment of GA In Dry AMD, Retinal Physician (http://www.retinalphysician.com/articleviewer.aspx?articleID=108371)

Awh CC et al. 2013. CFH and ARMS2 Genetic Polymorphisms Predict Response to Antioxidants and Zinc in Patients with Age-related Macular Degeneration. Ophtalmology 120:2317-2323 (http://www.aaojournal.org/article/S0161-6420(13)00679-9/abstract)

Tokarz P, Kaarniranta K, Blasiak J. 2013. Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology 14: 461- 482. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824279/)

Priya RR, Chew EY, Swaroop A. 2012. Genetic studies of age-related macular degeneration: lessons, challenges and opportunities for disease management. Ophthalmology, 119(12): 2526-2536. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514599/)

Fritsche LG, Fleckenstein M, Fiebig BS, et al. 2012. A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. IOVS, 53: 2112- 2118. (http://www.ncbi.nlm.nih.gov/pubmed/22427542)

Cruz-Jentoft AJ, Baryens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoulde M, Zamboni M. 2010. Sarcopenia : European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39(4): 412-423. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886201/)

Herzlich AA, Tuo J, Chan CC. 2008. Peroxisome proliferator-activated receptor and age- related macular degeneration. PPAR Research, article ID 389507. (http://www.hindawi.com/journals/ppar/2008/389507/)

Maeda A, Maeda T, Golczak M, Palczewski K. 2008. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J Biol Chem, 283: 26684-26693. (http://www.ncbi.nlm.nih.gov/pubmed/18658157)

Gehrs KM et al. 2006. Age-related macular degeneration: emerging pathogenetic and therapeutic concepts. Ann Med., 38:450-471 (http://www.ncbi.nlm.nih.gov/pubmed/17101537)

Marques-Vidal P, Ruidavets JB, Cambou JP, Ferrières J. 2003. Changes and determinants in cigarette smoking prevalence in southwester France, 1985-1997. Eur J Public Health, 13: 168-170. (http://eurpub.oxfordjournals.org/content/13/2/168)

Thompson DA,Gal A. 2003. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Progr Retinal Eye Res, 22: 683-703.
 (http://www.ncbi.nlm.nih.gov/pubmed/12892646)

Hyman L, Neborsky R. 2002. Risk factors for age-related macular degeneration : an update. Curr Opin Ophthalmol, 13(3): 171-175. (http://www.ncbi.nlm.nih.gov/pubmed/12011686)

AREDS report N°8, 2001. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. Arch Ophthalmol., 119:1417-1436
 (http://archopht.jamanetwork.com/article.aspx?articleid=268224)

Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. 2001. Risk factors for age-related macular degeneration : Poold findings from three continents. Ophthalmology, 108(4): 697 704. (http://www.ncbi.nlm.nih.gov/pubmed/11297486)

Marmorstein AD. 2001. The polarity of the retinal pigment epithelium. Traffic, 2(12): 867-872. (http://www.ncbi.nlm.nih.gov/pubmed/11737824)

Sparrow JR, Nakanishi K, Parish CA. 2000. The lipofuscin fluorophore A2E mediates blue-light- induced damage to retinal pigmented epithelial cells. IOVS, 41: 1981-1989. (http://iovs.arvojournals.org/article.aspx?articleid=2123554)

Scott IU, Smoddy WE, Schiffman J, Feuer WJ, Pappas CJ. 1999. Quality of lire of low-vision patients and the impact of low-vision services. Am J Ophthalmol, 128(1): 54-62.
 (http://www.ncbi.nlm.nih.gov/pubmed/10482094)

Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. 1998. The psychological impact of macular degeneration. Arch Ophthalmol, 116: 514-520.
 (http://archopht.jamanetwork.com/article.aspx?articleid=262237)

Klein R, Klein BEK, Jensen SC, Meuer SM, 1997. The five-year incidence and progression of age- related maculopathy : the Beaver Dam Eye Study. Ophthalmology, 104(1): 7-21.
 (http://www.ncbi.nlm.nih.gov/pubmed/9022098)

Moisseiev J, Alhalel A, Masuri R, Treister G. 1995. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol, 113(2): 185-189. (https://www.researchgate.net/publication/15667506_The_impact_of_the_macular_photocoagulation_study_results_on_the_treatment_of_exudative_age-related_macular_degeneration_Arch_Ophthalmol_113_185-189)

Marmor MF. 1990. Control of subretinal fluid: experimental and clinical studies. Eye (Lond), 4(Pt 2): 340-344. (http://www.ncbi.nlm.nih.gov/pubmed/2199242)

Feeney-Burns L, Eldred GE. 1983. The fate of the phagosome: conversion to ‘age pigment’ and impact in human retinal pigment epithelium. Trans Ophthalmol Soc UK, 103: 416-421.

Harman D. 1981. The aging process. Proc Natl Acad Sci U.S.A., 78(11): 7124-7128. (http://www.ncbi.nlm.nih.gov/pubmed/6947277)